SEC Form 3
FORM 3 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0104
Estimated average burden
hours per response: 0.5
1. Name and Address of Reporting Person*
GAITHER JOHN F JR

(Last) (First) (Middle)
C/O TALECRIS BIOTHERAPEUTICS HOLDINGS
P.O. BOX 110526 4101 RESEARCH COMMONS

(Street)
RESEARCH TRIANGLE PARK NC 27709

(City) (State) (Zip)
2. Date of Event Requiring Statement (Month/Day/Year)
09/30/2009
3. Issuer Name and Ticker or Trading Symbol
Talecris Biotherapeutics Holdings Corp. [ TLCR ]
4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
Exec.VP,General Counsel, Secy.
5. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4) 2. Amount of Securities Beneficially Owned (Instr. 4) 3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Stock 7,760(1) D
Table II - Derivative Securities Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4) 2. Date Exercisable and Expiration Date (Month/Day/Year) 3. Title and Amount of Securities Underlying Derivative Security (Instr. 4) 4. Conversion or Exercise Price of Derivative Security 5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 6. Nature of Indirect Beneficial Ownership (Instr. 5)
Date Exercisable Expiration Date Title Amount or Number of Shares
Options (right to buy) 04/01/2007(2) 12/06/2016 Common Stock 256,000(2) $11 D
Options (right to buy) 04/01/2009(3) 04/01/2018 Common Stock 420,000(3) $11 D
Explanation of Responses:
1. The number of shares reflected in this row includes 3,088 shares that have not yet vested of the Issuer's common stock that were granted by the Issuer to the Reporting Person on December 6, 2006 and which will vest on March 31, 2010, subject to the Reporting Person's continuous service with the Issuer through that date, as detailed in a restricted stock award agreement by and between the Issuer and the Reporting Person, dated as of December 6, 2006.
2. The securities being reported in this row are options to purchase the Issuer's common stock that were granted by the Issuer to the Reporting Person on December 6, 2006. 64,000 of these options have not vested and will vest and become exercisable on April 1, 2010, subject to the achievement of certain specified performance goals by the Issuer and subject to the Reporting Person remaining employed with the Issuer through that date, as detailed in a stock option award agreement by and between the Issuer and the Reporting Person, dated as of December 6, 2006.
3. The securities being reported in this row are options to purchase the Issuer's common stock that were granted by the Issuer to the Reporting Person on April 1, 2008. 210,000 of these options have not vested and will vest and become exercisable on April 1, 2010, subject to the achievement of certain specified performance goals by the Issuer and subject to the Reporting Person remaining employed with the Issuer through that date, as detailed in a stock option award agreement by and between the Issuer and the Reporting Person, dated as of April 1, 2008.
/s/ John F. Gaither, Jr. 09/30/2009
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.